INTS vs SYK · $7.7M cap vs P/E 35, rev $25.12B
Intensity Therapeutics, Inc. Common stock (INTS) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported SYK revenue for 2025-12-31 was $25.12B. Net income was $3.25B. Revenue was up 290.2% from 2024-12-31 to 2025-12-31. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
INTS currently screens at market cap $7.7M. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the INTS and SYK stock pages for the full models.
Not investment advice.